Zenas BioPharma (ZBIO) Non Operating Income (2023 - 2026)

Zenas BioPharma's Non Operating Income history runs 4 years deep, the most recent figure standing at -$3.6 million for Q1 2026.

• In Q1 2026, Non Operating Income fell 2401.9% year-over-year to -$3.6 million; the TTM figure through Mar 2026 stood at -$1.9 million (down 434.71% YoY), while the FY2025 annual figure was $5.2 million, up 2494.55% from the prior year.
• Non Operating Income was -$3.6 million for Q1 2026 at Zenas BioPharma, down from -$2.4 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $3.0 million in Q2 2025 to a low of -$3.7 million in Q4 2024.
• Historically, Non Operating Income has averaged -$10636.4 across 4 years, with a median of $472000.0 in 2024.
• The sharpest annual moves came in 2024 and 2026: Non Operating Income jumped 14962.5% in 2024, then plunged 2401.9% in 2026.
• A 4-year view of Non Operating Income shows it stood at $793000.0 in 2023, then plunged by 563.93% to -$3.7 million in 2024, then surged by 36.07% to -$2.4 million in 2025, then slumped by 54.63% to -$3.6 million in 2026.
• The last three Non Operating Income figures came in at -$3.6 million (Q1 2026), -$2.4 million (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.